Year: 2023
Type: article
Abstract: "Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis." Annals of the American Thoracic Society, 20(12), pp. 1683–1693
Institutions: Columbia University Irving Medical Center, University of Virginia, University of Chicago, National Jewish Health, Vanderbilt University, Vanderbilt University Medical Center, Harvard University, Massachusetts General Hospital, Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Royal Brompton Hospital, Imperial College London, Baylor College of Medicine, Brigham and Women's Hospital, Weill Cornell Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1159532084, G1200984374, G1266810589, G1311591790, G2176756438, G3864176819, G3922463029, G4186833208, G4518101676, Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences., G5095467882, INTEGRATED MOLECULAR PATHOGENESIS OF PULMONARY FIRBROSIS, Defining the biologic and physiologic trajectory of presymptomatic through advanced pulmonary fibrosis, Role of High Density Lipoproteins in Interstitial Lung Disease, Fibrotic lung disease on high-resolution computed tomography: predicting disease behaviour using computer algorithms., Role of polyunsaturated fatty acids in pulmonary fibrosis
OpenAlex ID: W4386699679
